CN1693476A - New determination method of semen fructose and glucose isomerase mutant used for said method - Google Patents
New determination method of semen fructose and glucose isomerase mutant used for said method Download PDFInfo
- Publication number
- CN1693476A CN1693476A CN 200410037442 CN200410037442A CN1693476A CN 1693476 A CN1693476 A CN 1693476A CN 200410037442 CN200410037442 CN 200410037442 CN 200410037442 A CN200410037442 A CN 200410037442A CN 1693476 A CN1693476 A CN 1693476A
- Authority
- CN
- China
- Prior art keywords
- glucose isomerase
- nucleotide sequence
- sequence
- fructose
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108700040099 Xylose isomerases Proteins 0.000 title claims abstract description 101
- 238000000034 method Methods 0.000 title claims abstract description 30
- 229930091371 Fructose Natural products 0.000 title claims description 46
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 title claims description 46
- 239000005715 Fructose Substances 0.000 title claims description 46
- 210000000582 semen Anatomy 0.000 title claims description 28
- 239000002773 nucleotide Substances 0.000 claims abstract description 25
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 25
- 102000004190 Enzymes Human genes 0.000 claims abstract description 11
- 108090000790 Enzymes Proteins 0.000 claims abstract description 11
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 10
- 108020004414 DNA Proteins 0.000 claims description 23
- 229920001184 polypeptide Polymers 0.000 claims description 15
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 15
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 15
- 230000008859 change Effects 0.000 claims description 13
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 12
- 230000009257 reactivity Effects 0.000 claims description 11
- 210000004027 cell Anatomy 0.000 claims description 9
- 239000008103 glucose Substances 0.000 claims description 8
- 241000894006 Bacteria Species 0.000 claims description 6
- 238000000746 purification Methods 0.000 claims description 6
- 230000008034 disappearance Effects 0.000 claims description 5
- 238000003780 insertion Methods 0.000 claims description 5
- 230000037431 insertion Effects 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 230000003197 catalytic effect Effects 0.000 claims description 3
- 210000003527 eukaryotic cell Anatomy 0.000 claims description 3
- 230000000968 intestinal effect Effects 0.000 claims description 3
- 229920005989 resin Polymers 0.000 claims description 3
- 239000011347 resin Substances 0.000 claims description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 2
- 238000003745 diagnosis Methods 0.000 claims description 2
- 102000053602 DNA Human genes 0.000 claims 1
- 206010021929 Infertility male Diseases 0.000 claims 1
- 208000007466 Male Infertility Diseases 0.000 claims 1
- 238000006911 enzymatic reaction Methods 0.000 claims 1
- 230000002452 interceptive effect Effects 0.000 claims 1
- 239000007791 liquid phase Substances 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 239000007790 solid phase Substances 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 abstract description 41
- 230000000694 effects Effects 0.000 abstract description 17
- 102000004169 proteins and genes Human genes 0.000 abstract description 10
- 230000008569 process Effects 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000012634 fragment Substances 0.000 description 38
- 238000006243 chemical reaction Methods 0.000 description 27
- 239000013612 plasmid Substances 0.000 description 23
- 239000006228 supernatant Substances 0.000 description 14
- 241001137870 Thermoanaerobacterium Species 0.000 description 12
- 230000003321 amplification Effects 0.000 description 10
- 230000000692 anti-sense effect Effects 0.000 description 10
- 238000003199 nucleic acid amplification method Methods 0.000 description 10
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 9
- 235000018102 proteins Nutrition 0.000 description 9
- 238000012408 PCR amplification Methods 0.000 description 8
- 230000001580 bacterial effect Effects 0.000 description 8
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 7
- 230000004087 circulation Effects 0.000 description 7
- 229940088598 enzyme Drugs 0.000 description 7
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 229960003487 xylose Drugs 0.000 description 7
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 6
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 6
- 238000000246 agarose gel electrophoresis Methods 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 239000003471 mutagenic agent Substances 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 201000010653 vesiculitis Diseases 0.000 description 6
- 238000001712 DNA sequencing Methods 0.000 description 5
- 108070000009 Free fatty acid receptors Proteins 0.000 description 5
- 125000000539 amino acid group Chemical group 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 230000014509 gene expression Effects 0.000 description 5
- 230000035772 mutation Effects 0.000 description 5
- 108020004707 nucleic acids Proteins 0.000 description 5
- 102000039446 nucleic acids Human genes 0.000 description 5
- 150000007523 nucleic acids Chemical class 0.000 description 5
- 210000001625 seminal vesicle Anatomy 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000013604 expression vector Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000007670 refining Methods 0.000 description 4
- 238000004088 simulation Methods 0.000 description 4
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 3
- 101710088194 Dehydrogenase Proteins 0.000 description 3
- 239000004366 Glucose oxidase Substances 0.000 description 3
- 101100383370 Squalus acanthias CFTR gene Proteins 0.000 description 3
- 241001137871 Thermoanaerobacterium saccharolyticum Species 0.000 description 3
- 238000006555 catalytic reaction Methods 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000012868 site-directed mutagenesis technique Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- UJOBWOGCFQCDNV-UHFFFAOYSA-N 9H-carbazole Chemical compound C1=CC=C2C3=CC=CC=C3NC2=C1 UJOBWOGCFQCDNV-UHFFFAOYSA-N 0.000 description 2
- 108010015776 Glucose oxidase Proteins 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 206010003883 azoospermia Diseases 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000002742 combinatorial mutagenesis Methods 0.000 description 2
- 229940116332 glucose oxidase Drugs 0.000 description 2
- 235000019420 glucose oxidase Nutrition 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 210000001236 prokaryotic cell Anatomy 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 239000012064 sodium phosphate buffer Substances 0.000 description 2
- 238000009210 therapy by ultrasound Methods 0.000 description 2
- 238000007669 thermal treatment Methods 0.000 description 2
- 210000001177 vas deferen Anatomy 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- ZAQJHHRNXZUBTE-WUJLRWPWSA-N D-xylulose Chemical compound OC[C@@H](O)[C@H](O)C(=O)CO ZAQJHHRNXZUBTE-WUJLRWPWSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 235000003283 Pachira macrocarpa Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 108020005091 Replication Origin Proteins 0.000 description 1
- 241001123227 Saccharomyces pastorianus Species 0.000 description 1
- 240000001085 Trapa natans Species 0.000 description 1
- 235000014364 Trapa natans Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- LKDRXBCSQODPBY-ZXXMMSQZSA-N alpha-D-fructopyranose Chemical compound OC[C@]1(O)OC[C@@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-ZXXMMSQZSA-N 0.000 description 1
- SRBFZHDQGSBBOR-LECHCGJUSA-N alpha-D-xylose Chemical compound O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-LECHCGJUSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 238000007357 dehydrogenase reaction Methods 0.000 description 1
- 238000006356 dehydrogenation reaction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000012407 engineering method Methods 0.000 description 1
- 235000021433 fructose syrup Nutrition 0.000 description 1
- 101150030521 gI gene Proteins 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- XUWPJKDMEZSVTP-LTYMHZPRSA-N kalafungina Chemical compound O=C1C2=C(O)C=CC=C2C(=O)C2=C1[C@@H](C)O[C@H]1[C@@H]2OC(=O)C1 XUWPJKDMEZSVTP-LTYMHZPRSA-N 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000009465 prokaryotic expression Effects 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 235000009165 saligot Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 238000006276 transfer reaction Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229920001221 xylan Polymers 0.000 description 1
- 150000004823 xylans Chemical class 0.000 description 1
Images
Landscapes
- Enzymes And Modification Thereof (AREA)
Abstract
A process for measuring the content of pectose in sperm by use of high-activity glucose isomerase mutant, the amino acid sequences of the high-activity glucose isomerase mutant series, the nucleotide sequence for coding said enzyme, and the gene and protein engineering and the process for preparing said glucose isomerase mutants are disclosed.
Description
Technical field the present invention relates to biology field and field of genetic engineering, specifically, relates to a kind of new seminal fluid fructose measuring method; The engineering of a series of glucose isomerase mutants and these enzymes and preparation method.
(Glucose isomerase is called for short GI to the technical background glucose isomerase; E.C.5.3.1.5), claim that again (Xylose isomerase is called for short XI to xylose isomerase; E.C.5.3.1.5) the catalysis conversion of glucose is a fructose, and therefore, glucose isomerase can be used for producing high fructose syrup industrial; But glucose isomerase also catalysis wood sugar is converted into xylulose, is xylan is converted into key enzyme in the ethanol approach.Therefore, glucose isomerase can be used for producing alcohol again industrial.But glucose isomerase also catalysis fructose is converted into glucose.Utilize this characteristic, the present invention is used in glucose isomerase medically first, is used for measuring the content of fructose in the seminal fluid.But existing glucose isomerase is owing to active low, the good inadequately content that is difficult to be used for measuring fructose in the seminal fluid of stability.The present invention has produced the glucose isomerase mutant of a series of high reactivities and good stability through gene and protein engineering technology, and these mutant can be effective to measure the content of fructose in the seminal fluid.
Fructose in the seminal fluid is secreted by seminal vesicle, and it is the main glucide that utilizes for sperm.In normal human's seminal fluid the content of fructose be the 9.11-17.67 mmole/liter.Measure fructose content in the refining, its purpose is: 1. weigh the function of seminal vesicle, during the seminal vesicle inflammation, fructose content descends; As fructose is zero, should consider that seminal vesicle lacks as; 2. differentiate the cause of disease of azoospermia, be mainly used in the azoospermia of differentiating that simple property obstruction of vas deferen and vas deferens, seminal vesicle lack as cause at present; 3. the function that reflects interstitial glands secretion testosterone indirectly; 4. fructose is formed in the seminal vesicle transformation by glucose in the blood in the refining, apparently higher than normally, should notice then that getting rid of the patient has non-diabetic as fructose content in the refining.The method of measuring seminal fluid fructose at present mainly contains chromatography, chemical method and Fructose dehydrogenase method.Chromatography is subjected to the restriction of instrument, and the rarer high performance liquid chromatograph of clinical labororatory also lacks relevant technologies.Chemical method is to utilize compound reactions such as fructose and Resorcinol, indoles or carbazole to produce colour-change, measures fructose content by colorimetric then.But the chemical colour reaction reaction must be carried out in the strongly-acid medium, and is dangerous; In addition, because the colour developing unstable products, so color reaction repeatability is very poor.Though it is gentle that the dehydrogenation enzyme process is a reaction conditions, measurement result is more accurate,, the developer instability of using in Fructose dehydrogenase itself and the Fructose dehydrogenase reaction, both all need facing with preceding fresh preparation, are very much time-consuming therefore; And Fructose dehydrogenase reagent costs an arm and a leg, so its commercial exploitation is restricted.So, still do not have a kind of more satisfactory and practical seminal fluid fructose measuring method so far.
(ATCC 49915 from Thermoanaerobacterium sachcharolyticum B6A bacterium in the present invention, USA) be separated to glucose isomerase (Lee Y.E.etal. in, Journal of General Microbiology 1993,139:1227-1234), its nucleotide sequence such as sequence table SEQ .ID NO.1, aminoacid sequence is sequence table SEQ .IDNO.2.Then, the present invention by gene and protein engineering technique improvement the glucose isomerase that is separated to of the present invention, the activity that to make its catalyzed conversion fructose be glucose has had and has significantly improved, and the stability of this glucose isomerase mutant and the expression level in intestinal bacteria have had and significantly improve.The present invention's glucose isomerase mutant in measuring seminal fluid aspect the fructose content more aforesaid chromatography, chemical method and fructose Off hydrogen enzyme have following characteristics: (1) is easy and simple to handle; (2) result is accurate; (3) mild condition; (4) with low cost.
Glucose isomerase mutant of the present invention can also be used in the human body or a certain organ or other organism seminal fluid DETERMINATION OF FRUCTOSE IN in the body.
Summary of the invention the object of the present invention is to provide a kind of seminal fluid fructose measuring method.Order of the present invention also is to provide a kind of high catalytic activity and heat-stable glucose isomerase mutant.The present invention also aims to provide the glucose isomerase mutant that uses high catalytic activity of the present invention effectively to measure fructose content in the seminal fluid.The present invention also aims to provide and use glucose isomerase mutant of the present invention to measure other organ or other organism seminal fluid fructose content in the human body.
The present invention from Thermoanaerobacterium sachcharolyticum B6A bacterium, be separated to glucose isomerase (Lee Y.E.etal., Journal of General Microbiology 1993,139:1227-1234).Then, the present invention is according to the secondary structure of the glucose isomerase that is separated to and the characteristic of simulation tertiary structure, by gene and protein engineering technique improvement this glucose isomerase, the activity that to make its catalyzed conversion fructose be glucose has had and has significantly improved, and the stability of this glucose isomerase mutant and the expression level in intestinal bacteria have had and significantly improve.
One aspect of the present invention provides a kind of seminal fluid fructose measuring method, and this method may further comprise the steps:
1) human body (or other organism, as ox, sheep, horse, dog) seminal fluid sample was handled 30 minutes in 80 ℃, centrifugal under the room temperature, supernatant liquor is changed in the clean tube again;
2) (BIO-RAD USA), removes in the seminal fluid the noisy material of glucose isomerase provided by the invention, and is centrifugal under the room temperature, collects supernatant liquor to add Chelex 100 resins;
3) get supernatant liquor, add CoCl
2And MgCl
2, add a kind of glucose isomerase mutant provided by the invention again, in 80 ℃ of reactions 10 minutes;
4) reaction product D-glucose is by the D-determination of glucose oxidase;
5), ask and calculate fructose content in the seminal fluid according to the fructose typical curve.
The present invention provides the nucleotide sequence of a series of high temperature resistant glucose isomerase mutants of coding on the other hand, described nucleotide sequence has the nucleotide sequence of sequence table SEQ .ID NO.3 or SEQ.ID NO.5 or SEQ.ID NO.7 or SEQ.ID NO.9 or the mutant form (〉=75% homology) of described nucleotide sequence, described sudden change comprises: disappearance, nonsense, insertion, missense, described sudden change do not comprise known codon degeneracy variation.
The present invention further provides nucleotide sequence coded corresponding sequence table SEQ .ID NO.4 or the polypeptide of SEQ.ID NO.5 or SEQ.IDNO.6 or SEQ.ID NO.10 aminoacid sequence or the modified forms (〉=90% homology) of described polypeptide by sequence table SEQ .ID NO.3 or SEQ.ID NO.5 or SEQ.ID NO.7 or SEQ.IDNO.9, on this modified forms function quite or relevant with the high reactivity glucose isomerase.
The present invention further provides the engineering method of high temperature resistant glucose isomerase mutant, this method may further comprise the steps:
1) according to gene pool (L09699) gene order design primer TF:5 ' AGCCTAGGTTAATTAACTTTAAGAAGGAGATATACATATGAATAAATATTTTGAGA A 3 ' and TR:5 ' ATAAGCTCAGCGGCGCGCCTTATTCTGCAAACAAATACT 3 ', utilize primer that TF and TR and conventional PCR skill dog (available from ATCC 49915, are amplified parent's glucose isomerase gene (TS-F) in USA) from Thermoanaerobacterium saccharolyticum;
2) secondary structure and the tertiary structure of analysis parent glucose isomerase are selected site R81, W139, R182, V186, Q59 and single site is carried out in T299 six sites or/and multidigit point combinatorial mutagenesis;
3) produce mutator gene by round pcr sudden change, (Promega, USA) connection must contain the plasmid of mutator gene with the mutator gene and the carrier pGEMT-Easy that produce;
4) plasmid is changed over to competence bacterial cell HB101, (DIFCO USA) filters out the clone of tool glucose isomerase activity on dull and stereotyped (containing 1% D-wood sugar and 50mg/L penbritin) at 1% MacConkey;
5) from the clone, extract plasmid DNA, determine that through dna sequencing the point mutation of introducing is errorless.
The present invention further provides the preparation method of high temperature resistant glucose isomerase mutant, this method may further comprise the steps:
1) will contain the plasmid transformed competence colibacillus bacterial cell HB101 of glucose isomerase mutant gene, be coated in MacConkey (DIFCO, USA) on dull and stereotyped (containing 1%D-wood sugar and 50mg/L penbritin), select for 37 ℃ to cultivate 36 hours, produce clone with glucose isomerase activity;
2) the single clone in liquid LB substratum (containing the 50mg/L penbritin) of inoculation cultivated;
3) centrifugal collection thalline, and be suspended from the sodium phosphate buffer (pH 6.5), add CoCl
2And MgCl
2Be respectively 250 μ M and 5mM to final concentration.Use the ultrasonic treatment bacterial cell then;
4) centrifugal and collection supernatant liquor;
5) supernatant liquor is through 80 ℃ of thermal treatments after 10 minutes, and is centrifugal and further collect supernatant liquor.Supernatant liquor is partially purified glucose isomerase.
Prepare in the method for high temperature resistant glucose isomerase mutant in the present invention, described carrier can be selected various carrier known in the art for use, includes but not limited to prokaryotic expression carrier pGEMT-Easy, pRSET and pET21.When producing high temperature resistant glucose isomerase provided by the invention, high temperature resistant glucose isomerase gene order can be linked to each other with expression regulation sequence, and then form high temperature resistant glucose isomerase expression vector.Expression vector contain replication origin and expression regulation sequence, promotor or/and enhanser or/and necessary machining information site or/and signal coding sequence.Expression vector also must contain alternative marker gene, as ampicillin resistance gene, kalamycin resistance gene.These expression vectors can prepare with recombinant DNA technology well known in the art, can be with reference to Sambrook, and et al., Molecularcloning:A laboratory manual.New York:Cold Spring Harbor Laboratory Press, 1989).
Prepare in the method for glucose isomerase in the present invention, described glucose isomerase can expression in prokaryotic cell prokaryocyte (as HB101, BL21, DH5 α) or eukaryotic cell (as yeast saccharomyces cerevisiae, finish red saccharomyces pastorianus), also can adopt any other proper method known in the art to be implemented in prokaryotic cell prokaryocyte or eukaryotic cell is expressed outward.
The accompanying drawing table illustrates that following accompanying drawing table is used to illustrate specific embodiments of the present invention, and is not used in qualification by the scope of the invention that claims defined.
The secondary structure of Fig. 1 parent glucose isomerase TS-F.
The simulation tertiary structure of Fig. 2 parent glucose isomerase TS-F.
Fig. 3 glucose isomerase mutant GI-1 polyacrylamide gel electrophoresis figure.
The specific activity of Fig. 4 parent glucose isomerase TS-F and glucose isomerase mutant.
The primer of table 1 parent glucose isomerase TS-F and glucose isomerase mutant amplified reaction.
Embodiment the following example only is used to the present invention is described and is not used in the scope of the present invention that limits.Implement unreceipted actual conditions person among the embodiment, the condition of conditioned disjunction manufacturers suggestion is carried out routinely.
Embodiment 1: the amplification of parental gene (TS-F) and the structure of carrier thereof
According to gene pool (L09699) gene order design primer TF and TR (seeing Table 1).Utilize primer to TF and the TR glucose isomerase coding parental gene (TS-F) that from T.saccharolyticum, increases.
Amplification reaction condition is: 20mM Tris-HCl, 10mM KCl, 10mM (NH
4)
2SO
4, 2mM MgSO
4, 0.1% Triton X-100,0.2mM dNTP, 400nM primer TF and 400nM primer TR, (Promega, USA) archaeal dna polymerase with a little T.saccharolyticum thalline of transfering loop picking, are transferred reaction volume to 50 μ l with sterilized water to 1.5UPfu again.
The pcr amplification reaction program is: 95 ℃ 3 minutes, 40 circle circulations: 95 ℃ 30 seconds, 50 ℃ 30 seconds and 72 ℃ 3 minutes, last 72 ℃ 10 minutes.The amplification gene be connected to carrier pGEMT-Easy (Promega, USA) on, plasmid pGMT-TS-F.Utilize rapid plasmid to prepare test kit (Marligen Bioscience, USA) extract plasmid pGMT-TS-F, determine that through dna sequencing the nucleotides sequence of TS-F glucose isomerase classifies sequence table SEQ .ID NO.1 as, amino acid sequence corresponding is sequence table SEQ .ID NO.2.
Embodiment 2: glucose isomerase secondary structure and tertiary structure analysis
(referring to McGufGIn L.J.etal., Bioinformatics 2000,16:404-405) to utilize PSIPRED software to obtain the secondary structure of glucose isomerase of parental gene coding.The glucose isomerase secondary structure the results are shown in Figure 1.Utilize the SWISS-PROT software analysis obtain the glucose isomerase of parental gene coding the simulation tertiary structure (referring to Reutrakul S.etal., The Journal of Clinical Endocrinology ﹠amp; Metabolism2001,86 (10): 5039-5044).The simulation tertiary structure of glucose isomerase is seen Fig. 2.Sharp because of BLAST software (see network address:
Http:// www.ncbi.nlm.nih.gov/BLAST/) other glucose isomerase gene in parent's glucose isomerase gene and the gene pool (is particularly derived from the glucose isomerase gene of thermoduric bacteria, GI gene as gene pool A72225, P45687 and P29441) compares, obtain glucose isomerase gene conservative sequence information.On the basis of parent GI secondary structure and tertiary structure, select site R81, W139, R182, V186, Q59 and T182 four sites to carry out single site and multidigit point combinatorial mutagenesis (seeing embodiment 3,4 and 5) again.
Embodiment 3: Sites Combination sudden change GI-1 more than the glucose isomerase
Site-directed mutagenesis technique is with reference to HO S.N.etal., and Gene 1989,77 (1): the description of 51-59 one literary composition.With plasmid pGEMT-TS-F is template, and the design primer is to 81AF and 81AR, 139FF and 139FR, 182AF and 182AR, 186TF and 186TR and 299QF and 299QR (seeing Table 1).Primer TF and TR see embodiment 1.To TF and 81AR, the TFAR fragment increases with primer; Primer is to 81AF and 139FR, and the AFFR fragment increases; Primer is to 139FF and 182AR, and the FFAR fragment increases; Primer is to 182AF and 186TR, and the AFTR fragment increases; Primer is to 186TF and 299QR, and the TFQR fragment increases; Primer is to 299QF and TR, and the QFTR fragment increases.Amplification reaction condition is: 20mM Tris-HCl, 10mM KCl, 10mM (NH
4)
2SO
4, 2mM MgSO
4, 0.1% Triton X-100,0.2mM dNTP, the single primer of 400nM (from a pair of primer), 1.5U Pfu archaeal dna polymerase, 40ngpGMT-TS-F transfers reaction volume to 50ul with sterilized water again.The pcr amplification reaction program is: 95 ℃ 3 minutes, 35 circle circulations: 95 ℃ 50 seconds, 52 ℃ 30 seconds and 72 ℃ 3 minutes, last 72 ℃ 5 minutes.(QIAGEN German) reclaims, and obtains TFAR fragment, AFFR fragment, FFAR fragment, AFTR fragment, TFQR and QFTR fragment respectively through the separation of 1% agarose gel electrophoresis and with test kit QIAquick DNA.Full-length gene then increases.Amplification reaction condition is: 20mM Tris-HCl, 10mM KCl, 10mM (NH
4)
2SO
4, 2mM MgSO
40.1% Triton X-100,0.2mM dNTP, 400nM primer TF and 400nM TR, 1.5U Pfu archaeal dna polymerase, 40ng TFAR fragment, 40ng AFFR fragment, 40ng FFAR fragment, 40ng AFTR fragment, 40ng TFQR fragment and 40ng QFTR fragment are transferred reaction volume to 50 μ l with sterilized water again.The pcr amplification reaction program is: 95 ℃ 3 minutes, 35 circle circulations: 95 ℃ 50 seconds, 52 ℃ 30 seconds and 72 ℃ 3 minutes, last 72 ℃ 5 minutes.Reclaim through the separation of 1% agarose gel electrophoresis and with test kit QIAquick DNA, obtain total length mutator gene GI-1.GI-1 is connected with carrier pGEMT-Easy, gets plasmid pGEMT-GI-1.Change plasmid pGEMT-GI-1 over to competence bacterial cell HB101, (DIFCO USA) filters out the clone of tool glucose isomerase activity on dull and stereotyped (containing 1% D-wood sugar and 50mg/L penbritin) at 1%MacConkey.From the clone, extract plasmid pGEMT-GI-1 DNA, determine that through dna sequencing the point mutation of introducing is errorless.The G1-1 sequence is seen sequence table SEQ .ID NO.3-4.
Embodiment 4: Sites Combination sudden change GI-2 more than the glucose isomerase
Site-directed mutagenesis technique is with reference to HO S.N.etal., and Gene 1989,77 (1): the description of 51-59 one literary composition.With plasmid pGEMT-TS-F is template, and the design primer is to 81AF and 81AR, 139FF and 139FR, 182AF and 182AR, 187SF and 187SR and 299IF and 299IR (seeing Table 1).Primer TF and TR see embodiment 1.To TF and 81AR, the TFAR fragment increases with primer; Primer is to 81AF and 139FR, and the AFFR fragment increases; Primer is to 139FF and 182AR, and the FFAR fragment increases; Primer is to 182AF and 187SR, and the AFSR fragment increases; Primer is to 187SF and 299IR, and the SFIR fragment increases; Primer is to 299IF and TR, and the IFTR fragment increases.Amplification reaction condition is: 20mM Tris-HCl, 10mM KCl, 10mM (NH
4)
2SO
4, 2mM MgSO
4, 0.1% Triton X-100,0.2mM dNTP, the single primer of 400nM (from a pair of primer), 1.5U Pfu archaeal dna polymerase, 20ngpGMT-TS-F transfers reaction volume to 50 μ l with sterilized water again.The pcr amplification reaction program is: 95 ℃ 3 minutes, 35 circle circulations: 95 ℃ 50 seconds, 52 ℃ 30 seconds and 72 ℃ 3 minutes, last 72 ℃ 5 minutes.Reclaim through the separation of 1% agarose gel electrophoresis and with QIAquick DNA, obtain TFAR fragment, AFFR fragment, FFAR fragment, AFSR fragment, SFIR and IFTR fragment respectively.Full-length gene then increases.Amplification reaction condition is: 20mM Tris-HCl, 10mMKCl, 10mM (NH
4)
2SO
4, 2mM MgSO
40.1% Triton X-100,0.2mM dNTP, 400nM primer TF and 400nM TR, 1.5U Pfu archaeal dna polymerase, 40ng TFAR fragment, 40ng AFFR fragment, 40ngFFAR fragment, 40ng AFSR fragment, 40ng SFIR fragment and 40ng IFTR fragment are transferred reaction volume to 50 μ l with sterilized water again.The pcr amplification reaction program is: 95 ℃ 3 minutes, 35 circle circulations: 95 ℃ 50 seconds, 52 ℃ 30 seconds and 72 ℃ 3 minutes, last 72 ℃ 5 minutes.Reclaim through the separation of 1% agarose gel electrophoresis and with QIAquick DNA, obtain total length mutator gene GI-2.GI-2 is connected with carrier pGEMT-Easy, gets plasmid pGEMT-GI-2.Change plasmid pGEMT-GI-2 over to competence bacterial cell HB101, (DIFCO USA) filters out the clone of tool glucose isomerase activity on dull and stereotyped (containing 1%D-wood sugar and 50mg/L penbritin) at 1% MacConkey.From the clone, extract plasmid pGEMT-G1-2DNA, determine that through dna sequencing the point mutation of introducing is errorless.The GI-2 sequence is seen sequence table SEQ .ID NO.5-6.
Embodiment 5: the single site mutation of glucose isomerase
Site-directed mutagenesis technique is with reference to HO S.N.etal., and Gene 1989,77 (1): the description of 51-59 one literary composition.With plasmid pGEMT-GI-1 (referring to embodiment 3) is template, and the design primer sports Asp (D) to 139DF and 139DR (seeing Table 1) with the Phe (F) in the 139th site in the GI-1 aminoacid sequence, obtains mutant GI-F139D.Primer TF and TR see embodiment 1.Utilize primer to TF and 139DR, amplification TFDR fragment; Primer is to 139DF and TR, and the DFTR fragment increases.Amplification reaction condition is: 20mM Tris-HCl, 10mM KCl, 10mM (NH
4)
2SO
4, 2mMMgSO
4, 0.1% Triton X-100,0.2mM dNTP, the single primer of 400nM (from a pair of primer), 1.5U PfuDNA polysaccharase, 40ng pGEMT-GI-1 transfers reaction volume to 50 μ l with sterilized water again.The pcr amplification reaction program is: 95 ℃ 3 minutes, 35 circle circulations: 95 ℃ 50 seconds, 52 ℃ 30 seconds and 72 ℃ 3 minutes, last 72 ℃ 5 minutes.Reclaim through the separation of 1% agarose gel electrophoresis and with QIAquick DNA, obtain TFDR fragment and DFTR fragment.Full-length gene then increases.Amplification reaction condition is: 20mM Tris-HCl, 10mM KCl, 10mM (NH
4)
2SO
4, 2mM MgSO
4, 0.1% Triton X-100,0.2mM dNTP, 400nM primer TF and 400nMTR, 1.5U Pfu archaeal dna polymerase, 40ng TFDR and 40ng DFTR transfer reaction volume to 50 μ l with sterilized water again.The pcr amplification reaction program is: 95 ℃ 3 minutes, 35 circle circulations: 95 ℃ 50 seconds, 52 ℃ 30 seconds and 72 ℃ 3 minutes, last 72 ℃ 5 minutes.Reclaim through the separation of 1% agarose gel electrophoresis and with QIAquick DNA, obtain total length mutator gene GI-F139D.GI-F139D is connected with carrier pGEMT-Easy, gets plasmid pGEMT-GI-F139D.Change plasmid pGEMT-GI-F139D over to competence bacterial cell HB101, (DIFCO USA) filters out the clone of tool glucose isomerase activity on dull and stereotyped (containing 1% D-wood sugar and 50mg/L penbritin) at 1% MacConkey.From the clone, extract plasmid pGEMT-GI-F139D DNA, determine that through dna sequencing the point mutation of introducing is errorless.The GI-F139D sequence is seen sequence table SEQ .ID NO.7-8.
According to similar step, with plasmid pGEMT-GI-1 (referring to embodiment 3) is template, the design primer is to 299EF and 299ER (seeing Table 1), the Gln (Q) in the 299th site in the GI-1 aminoacid sequence is sported Glu (E), make up mutant GI-Q299E, mutant is connected with carrier pGEMT-Easy, gets plasmid pGEMT-GI-Q299E.The GI-Q299E sequence is seen sequence table SEQ .ID NO.9-10.
Embodiment 6: the extraction and purification of glucose isomerase TS-F
The extraction and purification main reference Lee Y.E.etal. of glucose isomerase, Journal of GeneralMicrobiology.1993,139:1227-1234.
The plasmid pGEMT-TS-F transformed competence colibacillus bacterial cell HB101 that will contain parent's glucose isomerase gene, (DIFCO USA) on dull and stereotyped (containing 1%D-wood sugar and 50mg/L penbritin), selects for 37 ℃ to cultivate 36 hours at MacConkey.Inoculate in the single 5ml of the being cloned in LB liquid nutrient medium (containing the 50mg/L penbritin) and cultivated 16 hours.Centrifugal collection thalline, and be suspended in the 1ml 20mM sodium phosphate buffer (pH 6.5), add CoCl
2And MgCl
2Be respectively 250 μ M and 5mM to final concentration.Use the ultrasonic treatment bacterial cell then.Centrifugal (10 ℃, 15,000 g, 15 minutes) also collect supernatant liquor.After 10 minutes, centrifugal (10 ℃, 15,000 g, 15 minutes) also collect supernatant liquor to supernatant liquor through 80 ℃ of thermal treatments.Supernatant liquor is partially purified glucose isomerase, and the mensuration and the seminal fluid fructose content that can be used for enzymic activity are measured.
Embodiment 7: the extraction and purification of glucose isomerase mutant
The extraction and purification of glucose isomerase mutant GI-1 and embodiment 5 with, be used plasmid be pGEMT-GI-1.The glucose isomerase of purifying is seen Fig. 3.The also described like this extraction and purification of other glucose isomerase mutant.
Embodiment 8: the active mensuration of parent's glucose isomerase TS-F
Get the glucose isomerase of 10 μ l, be added in the fructose and 20mM buffer solution of sodium phosphate of 90 μ l 1.0M (pH 6.5), and contain CoCl by embodiment 5 preparation
2And MgCl
2Final concentration is respectively 250 μ M and 5mM, reacts on 80 ℃ and carries out 10 minutes.Reactant is put on ice with termination reaction.Reaction product D-glucose is by the D-determination of glucose oxidase, and measuring method is referring to Trinder, P.Ann.Clin.Biochem.1981, and 18:64-67, and Shanghai Ke Hua-Dong water chestnut diagnosis is with the Reagent kit of glucose working instructions of product company limited.Use Coomassie
(PIERCE USA) measures zymoprotein concentration to Plus Protein AssayReagent Kit.One unit specific enzyme activity is defined as under these conditions per minute, and to transform micromole's fructose be the required enzyme amount of glucose.Fig. 4 shows the specific activity of parent TS-F glucose isomerase.
Embodiment 9: glucose isomerase mutant GI-1 determination of activity
Glucose isomerase mutant GI-1 determination of activity and embodiment 8 are together.The also described like this mensuration of the activity of other glucose isomerase mutant.Fig. 4 shows the difference of glucose isomerase mutant mutant and parent TS-F glucose isomerase specific enzyme activity.
Embodiment 10: measure the seminal fluid fructose content with glucose isomerase mutant
In 80 ℃ of processing 30 minutes, centrifugal under the room temperature (15,000g, 20 minutes) changed supernatant liquor in one clean tube over to again with human seminal fluid's sample.(B1O-RAD, USA) to final concentration 20%, in 80 ℃ of reactions 30 minutes, centrifugal under the room temperature (15,000g 15 minutes) collected supernatant liquor to add Chelex 100 resins.Get 180 μ l supernatant liquors, add CoCl
2And MgCl
2Be respectively 250 μ M and 5mM to final concentration, add that 20 μ l extract by embodiment 6 and the glucose isomerase mutant of purifying, in 80 ℃ of reactions 10 minutes.Reaction product D-glucose is by the D-glucose oxidase method and press embodiment 7 mensuration.According to fructose typical curve (be the fructose standardized solution of 0mM, 0.5mM, 1.0mM, 2mM, 4mM, 8mM and 10mM and formulate), ask and calculate fructose content in the seminal fluid by embodiment 7 by concentration.According to similar step, measure the fructose content in other organism refining.
The present invention is not subjected to the restriction of above-mentioned concrete text description, and the present invention can make various changes in the generalized scope of claims institute.These change all within the scope of the present invention.
The primer of table 1 parent glucose isomerase TS-F and glucose isomerase mutant pcr amplification reaction
| The parent | Primer is right |
| ????TS-F | TF：5′agcctaggttaattaactttaagaaggagatatacatatgaataaat attttgagaa?3′ TR：5′ataagctcagcggcgcgccttattctgcaaacaaatact?3′ |
| Mutant | Primer is right |
| ????GI-1 | 81AF：5′tagcgaaagcaagggtagaagcagcatttga?3′ 81AR：5′tctacccttgctttcgctatatccataggat?3′ 139FF：5′aagttttgtttggtaccgcaaatcttttctc?3′ 139FR：5′gcggtaccaaacaaaacttttgtcttgctgg?3′ 182AF：5′agcttggcgcggaaaactacgtattttgggg?3′ 182AR：5′tagttttccgcgccaagctccttagtaatct?3′ 186TF：5′aaaactacacattttggggtggaagagaagg?3′ 186TR：5′ccccaaaatgtgtagttttcgcggccaagct?3′ 299QF：5′acgcaaatcaaggcgacatgcttttgggatg?3′ 299QR：5′atgtcgccttgatttgcgtcaattgatccta?3′ |
| ????GI-2 | 81AF：5′tagcgaaagcaagggtagaagcagcatttga?3′ 81AR：5′tctacccttgctttcgctatatccataggat?3′ 139FF：5′aagttttgtttggtaccgcaaatcttttctc?3′ 139FR：5′gcggtaccaaacaaaacttttgtcttgctgg?3′ 182AF：5′agcttggcgcggaaaactacgtattttgggg?3′ 182AR：5′tagttttccgcgccaagctccttagtaatct?3′ 187SF：5′actacgtgagctggggtggaagagaagggt?3′ 187SR：5′ccaccccagctcacgtagttttcgcggccaa?3′ 299IF：5′acgcaaatattggcgacatgcttttgggatg?3′ 299IR：5′atgtcgccaatatttgcgtcaattgatccta?3′ |
| ????GI-F139D | 139DF：5′aagttttggatggtaccgcaaatcttttctc?3′ 139DR：5′gcggtaccatccaaaacttttgtcttgctgg?3′ |
| ????GI-D299E | 299EF：5′acgcaaatgaaggcgacatgcttttgggatg?3′ 299ER：5′atgtcgccttcatttgcgtcaattgatccta?3′ |
Sequence table
Sequence (SEQ.ID NO.) 1
(a) sequence signature:
* length: 1320 base pairs
* type: nucleic acid
* chain: two strands
* topological framework: linearity
(b) molecule type: DNA
(c) suppose: not
(d) antisense: not
(e) initial source: Thermoanaerobacterium sachcharolyticum B6A.
1?atgaataaat?attttgagaa?cgtatctaaa?ataaaatatg?aaggaccaaa?atcaaataat
61?ccttattcct?ttaaatttta?caatccagag?gaagtaatcg?atggcaagac?gatggaggag
121?catctccgct?tttctatagc?ttattggcac?acttttactg?ctgatggaac?agatcaattt
181?ggcaaggcta?ctatgcaaag?accatggaac?cactacacag?atcctatgga?tatagcgaaa
241?cgaagggtag?aagcagcatt?tgagtttttt?gataagataa?atgcaccttt?cttctgcttc
301?catgataggg?atattgcccc?tgaaggagat?actcttagag?agacaaacaa?aaacttagat
361?acaatagttg?ctatgataaa?ggattactta?aagaccagca?agacaaaagt?tttgtggggt
421?accgcaaatc?ttttctccaa?tccgagattt?gtacatggtg?catcaacatc?ctgcaatgct
481?gacgtttttg?catattctgc?agcgcaagtc?aaaaaagccc?ttgagattac?taaggagctt
541?ggccgcgaaa?actacgtatt?ttggggtgga?agagaagggt?acgagacgct?tctcaataca
601?gatatggagt?tagagcttga?taactttgca?agatttttgc?acatggctgt?tgactatgca
661?aaggaaatcg?gctttgaagg?tcagttcttg?attgagccga?agccaaagga?gcctacaaaa
721?catcaatacg?actttgacgt?ggcaaatgta?ttggcattct?tgagaaaata?cgaccttgac
781?aaatatttca?aagtaaatat?cgaagcaaac?catgcgacat?tggcattcca?cgacttccaa
841?catgagctaa?gatacgccag?aataaacggt?gtattaggat?caattgacgc?aaatacaggc
901?gacatgcttt?tgggatggga?tacggaccag?ttccctacag?atatacgcat?gacaacgctt
961?gctatgtatg?aagtcataaa?gatgggtgga?tttgacaaag?gtggccttaa?ctttgatgca
1021?aaagtaagac?gtgcttcatt?tgagccagaa?gatcttttct?taggtcacat?agcaggaatg
1081?gatgcttttg?caaaaggctt?taaagttgct?tacaagcttg?tgaaagatgg?cgtatttgac
1141?aagttcatcg?aagaaagata?cgcaagctac?aaagaaggca?ttggcgctga?tattgtaagc
1201?ggtaaagctg?acttcaagag?ccttgaaaag?tatgcattag?agcacagcca?gattgtaaac
1261?aaatcaggca?gacaagagct?attagaatca?atcctaaatc?agtatttgtt?tgcagaataa
Sequence (SEQ.ID NO.) 2
(a) sequence signature:
* length: 440 amino-acid residues
* type: polypeptide
* chain: strand
* topological framework: linearity
(b) molecule type: Protein
(c) suppose: not
(d) antisense: not
(e) initial source: Thermoanaerobacterium sachcharolyticum B6A.
mnkyfenvsk?ikyegpksnn?pysfkfynpe?evidgktmee?hlrfsiaywh?tftadgtdqf
gkatmqrpwn?hytdpmdiak?rrveaafeff?dkinapffcf?hdrdiapegd?tlretnknld
tivamikdyl?ktsktkvlwg?tanlfsnprf?vhgastscna?dvfaysaaqv?kkaleitkel
grenyvfwgg?regyetllnt?dmeleldnfa?rflhmavdya?keigfegqfl?iepkpkeptk
hqydfdvanv?laflrkydld?kyfkvniean?hatlafhdfq?helryaring?vlgsidantg
dmllgwdtdq?fptdirmttl?amyevikmgg?fdkgglnfda?kvrrasfepe?dlflghiagm
dafakgfkva?yklvkdgvfd?kfieeryasy?kegigadivs?gkadfkslek?yalehsqivn
ksgrqelles?ilnqylfae
Sequence (SEQ.ID NO.) 3
(a) sequence signature:
* length: 1320 base pairs
* type: nucleic acid
* chain: two strands
* topological framework: linearity
(b) molecule type: DNA
(c) suppose: not
(d) antisense: not
(e) initial source: Thermoanaerobacterium sachcharolyticum B6A.
1?atgaataaat?attttgagaa?cgtatctaaa?ataaaatatg?aaggaccaaa?atcaaataat
61?ccttattcct?ttaaatttta?caatccagag?gaagtaatcg?atggcaagac?gatggaggag
121?catctccgct?tttctatagc?ttattggcac?acttttactg?ctgatggaac?agatcaattt
181?ggcaaggcta?ctatgcaaag?accatggaac?cactacacag?atcctatgga?tatagcgaaa
241?gcaagggtag?aagcagcatt?tgagtttttt?gataagataa?atgcaccttt?cttctgcttc
301?catgataggg?atattgcccc?tgaaggagat?actcttagag?agacaaacaa?aaacttagat
361?acaatagttg?ctatgataaa?ggattactta?aagaccagca?agacaaaagt?tttgtttggt
421?accgcaaatc?ttttctccaa?tccgagattt?gtacatggtg?catcaacatc?ctgcaatgct
481?gacgtttttg?catattctgc?agcgcaagtc?aaaaaagccc?ttgagattac?taaggagctt
541?ggcgcggaaa?actacacatt?ttggggtgga?agagaagggt?acgagacgct?tctcaataca
601?gatatggagt?tagagcttga?taactttgca?agatttttgc?acatggctgt?tgactatgca
661?aaggaaatcg?gctttgaagg?tcagttcttg?attgagccga?agccaaagga?gcctacaaaa
721?catcaatacg?actttgacgt?ggcaaatgta?ttggcattct?tgagaaaata?cgaccttgac
781?aaatatttca?aagtaaatat?cgaagcaaac?catgcgacat?tggcattcca?cgacttccaa
841?catgagctaa?gatacgccag?aataaacggt?gtattaggat?caattgacgc?aaatcaaggc
901?gacatgcttt?tgggatggga?tacggaccag?ttccctacag?atatacgcat?gacaacgctt
961?gctatgtatg?aagtcataaa?gatgggtgga?tttgacaaag?gtggccttaa?ctttgatgca
1021?aaagtaagac?gtgcttcatt?tgagccagaa?gatcttttct?taggtcacat?agcaggaatg
1081?gatgcttttg?caaaaggctt?taaagttgct?tacaagcttg?tgaaagatgg?cgtatttgac
1141?aagttcatcg?aagaaagata?cgcaagctac?aaagaaggca?ttggcgctga?tattgtaagc
1201?ggtaaagctg?acttcaagag?ccttgaaaag?tatgcattag?agcacagcca?gattgtaaac
1261?aaatcaggca?gacaagagct?attagaatca?atcctaaatc?agtatttgtt?tgcagaataa
Sequence (SEQ.ID NO.) 4
(a) sequence signature:
* length: 440 amino-acid residues
* type: polypeptide
* chain: strand
* topological framework: linearity
(b) molecule type: Protein
(c) suppose: not
(d) antisense: not
(e) initial source: Thermoanaerobacterium sachcharolyticum B6A.
MNKYFENVSKIKYEGPKSNNPYSFKFYNPEEVIDGKTMEEHLRFSIAYWHTFTADGTDQF
GKATMQRPWNHYTDPMDIAKARVEAAFEFFDKINAPFFCFHDRDIAPEGDTLRETNKNLD
TIVAMIKDYLKTSKTKVLFGTANLFSNPRFVHGASTSCNADVFAYSAAQVKKALEITKEL
GAENYTFWGGREGYETLLNTDMELELDNFARFLHMAVDYAKEIGFEGQFLIEPKPKEPTK
HQYDFDVANVLAFLRKYDLDKYFKVNIEANHATLAFHDFQHELRYARINGVLGSIDANQG
DMLLGWDTDQFPTDIRMTTLAMYEVIKMGGFDKGGLNFDAKVRRASFEPEDLFLGHIAGM
DAFAKGFKVAYKLVKDGVFDKFIEERYASYKEGIGADIVSGKADFKSLEKYALEHSQIVN
KSGRQELLESILNQYLFAE*
Sequence (SEQ.ID NO.) 5
(a) sequence signature:
* length: 1320 base pairs
* type: nucleic acid
* chain: two strands
* topological framework: linearity
(b) molecule type: DNA
(c) suppose: not
(d) antisense: not
(e) initial source: Thermoanaerobacterium sachcharolyticum B6A.
1?atgaataaat?attttgagaa?cgtatctaaa?ataaaatatg?aaggaccaaa?atcaaataat
61?ccttattcct?ttaaatttta?caatccagag?gaagtaatcg?atggcaagac?gatggaggag
121?catctccgct?tttctatagc?ttattggcac?acttttactg?ctgatggaac?agatcaattt
181?ggtaaggcta?ctatgcaaag?accatggaac?cactacacag?atcctatgga?tatagcgaaa
241?gcaagggtag?aagcagcatt?tgagtttttt?gataagataa?atgcaccttt?cttctgcttc
301?catgataggg?atattgcccc?tgaaggagat?actcttagag?agacaaacaa?aaacttagat
361?acaatagttg?ctatgataaa?ggattactta?aagaccagca?agacaaaagt?tttgtttggt
421?accgcaaatc?ttttctccaa?tccgagattt?gtacatggtg?catcaacatc?ctgcaatgct
481?gacgtttttg?catattctgc?agcgcaagtc?aaaaaagccc?ttgagattac?taaggagctt
541?ggcgcggaaa?actacgtgag?ctggggtgga?agagaagggt?acgagacgct?tctcaataca
601?gatatggagt?tagagcttga?taactttgca?agatttttgc?acatggctgt?tgactatgca
661?aaggaaatcg?gctttgaagg?tcagttcttg?attgagccga?agccaaagga?gcctacaaaa
721?catcaatacg?actttgacgt?ggcaaatgta?ttggcattct?tgagaaaata?cgaccttgac
781?aaatatttca?aagtaaatat?cgaagcaaac?catgcgacat?tggcattcca?cgacttccaa
841?catgagctaa?gatacgccag?aataaacggt?gtattaggat?caattgacgc?aaatattggc
901?gacatgcttt?tgggatggga?tacggaccag?ttccctacag?atatacgcat?gacaacgctt
961?gctatgtatg?aagtcataaa?gatgggtgga?tttgacaaag?gtggccttaa?ctttgatgca
1021?aaagtaagac?gtgcttcatt?tgagccagaa?gatcttttct?taggtcacat?agcaggaatg
1081?gatgcttttg?caaaaggctt?taaagttgct?tacaagcttg?tgaaagatgg?cgtatttgac
1141?aagttcatcg?aagaaagata?cgcaagctac?aaagaaggca?ttggcgctga?tattgtaagc
1201?ggtaaagctg?acttcaagag?ccttgaaaag?tatgcattag?agcacagcca?gattgtaaac
1261?aaatcaggca?gacaagagct?attagaatca?atcctaaatc?agtatttgtt?tgcagaataa
Sequence (SEQ.ID NO.) 6
(a) sequence signature:
* length: 440 amino-acid residues
* type: polypeptide
* chain: strand
* topological framework: linearity
(b) molecule type: Protein
(c) suppose: not
(d) antisense: not
(e) initial source: Thermoanaerobacterium sachcharolyticum B6A.
MNKYFENVSKIKYEGPKSNNPYSFKFYNPEEVIDGKTMEEHLRFSIAYWHTFTADGTDQF
GKATMQRPWNHYTDPMDIAKARVEAAFEFFDKINAPFFCFHDRDIAPEGDTLRETNKNLD
TIVAMIKDYLKTSKTKVLFGTANLFSNPRFVHGASTSCNADVFAYSAAQVKKALEITKEL
GAENYVSWGGREGYETLLNTDMELELDNFARFLHMAVDYAKEIGFEGQFLIEPKPKEPTK
HQYDFDVANVLAFLRKYDLDKYFKVNIEANHATLAFHDFQHELRYARINGVLGSIDANIG
DMLLGWDTDQFPTDIRMTTLAMYEVIKMGGFDKGGLNFDAKVRRASFEPEDLFLGHIAGM
DAFAKGFKVAYKLVKDGVFDKFIEERYASYKEGIGADIVSGKADFKSLEKYALEHSQIVN
KSGRQELLESILNQYLFAE*
Sequence (SEQ.ID NO.) 7
(a) sequence signature:
* length: 1320 base pairs
* type: nucleic acid
* chain: two strands
* topological framework: linearity
(b) molecule type: DNA
(c) suppose: not
(d) antisense: not
(e) initial source: Thermoanaerobacterium sachcharolyticum B6A.
1?atgaataaat?attttgagaa?cgtatctaaa?ataaaatatg?aaggaccaaa?atcaaataat
61?ccttattcct?ttaaatttta?caatccagag?gaagtaatcg?atggcaagac?gatggaggag
121?catctccgct?tttctatagc?ttattggcac?acttttactg?ctgatggaac?agatcaattt
181?ggcaaggcta?ctatgcaaag?accatggaac?cactacacag?atcctatgga?tatagcgaaa
241?gcaagggtag?aagcagcatt?tgagtttttt?gataagataa?atgcaccttt?cttctgcttc
301?catgataggg?atattgcccc?tgaaggagat?actcttagag?agacaaacaa?aaacttagat
361?acaatagttg?ctatgataaa?ggattactta?aagaccagca?agacaaaagt?tttggatggt
421?accgcaaatc?ttttctccaa?tccgagattt?gtacatggtg?catcaacatc?ctgcaatgct
481?gacgtttttg?catattctgc?agcgcaagtc?aaaaaagccc?ttgagattac?taaggagctt
541?ggcgcggaaa?actacacatt?ttggggtgga?agagaagggt?acgagacgct?tctcaataca
601?gatatggagt?tagagcttga?taactttgca?agatttttgc?acatggctgt?tgactatgca
661?aaggaaatcg?gctttgaagg?tcagttcttg?attgagccga?agccaaagga?gcctacaaaa
721?catcaatacg?actttgacgt?ggcaaatgta?ttggcattct?tgagaaaata?cgaccttgac
781?aaatatttca?aagtaaatat?cgaagcaaac?catgcgacat?tggcattcca?cgacttccaa
841?catgagctaa?gatacgccag?aataaacggt?gtattaggat?caattgacgc?aaatcaaggc
901?gacatgcttt?tgggatggga?tacggaccag?ttccctacag?atatacgcat?gacaacgctt
961?gctatgtatg?aagtcataaa?gatgggtgga?tttgacaaag?gtggccttaa?ctttgatgca
1021?aaagtaagac?gtgcttcatt?tgagccagaa?gatcttttct?taggtcacat?agcaggaatg
1081?gatgcttttg?caaaaggctt?taaagttgct?tacaagcttg?tgaaagatgg?cgtatttgac
1141?aagttcatcg?aagaaagata?cgcaagctac?aaagaaggca?ttggcgctga?tattgtaagc
1201?ggtaaagctg?acttcaagag?ccttgaaaag?tatgcattag?agcacagcca?gattgtaaac
1261?aaatcaggca?gacaagagct?attagaatca?atcctaaatc?agtatttgtt?tgcagaataa
Sequence (SEQ.ID NO.) 8
(a) sequence signature:
* length: 440 amino-acid residues
* type: polypeptide
* chain: strand
* topological framework: linearity
(b) molecule type: Protein
(c) suppose: not
(d) antisense: not
(e) initial source: Thermoanaerobacterium sachcharolyticum B6A.
MNKYFENVSKIKYEGPKSNNPYSFKFYNPEEVIDGKTMEEHLRFSIAYWHTFTADGTDQF
GKATMQRPWNHYTDPMDIAKARVEAAFEFFDKINAPFFCFHDRDIAPEGDTLRETNKNLD
TIVAMIKDYLKTSKTKVLDGTANLFSNPRFVHGASTSCNADVFAYSAAQVKKALEITKEL
GAENYTFWGGREGYETLLNTDMELELDNFARFLHMAVDYAKEIGFEGQFLIEPKPKEPTK
HQYDFDVANVLAFLRKYDLDKYFKVNIEANHATLAFHDFQHELRYARINGVLGSIDANQG
DMLLGWDTDQFPTDIRMTTLAMYEVIKMGGFDKGGLNFDAKVRRASFEPEDLFLGHIAGM
DAFAKGFKVAYKLVKDGVFDKFIEERYASYKEGIGADIVSGKADFKSLEKYALEHSQIVN
KSGRQELLESILNQYLFAE*
Sequence (SEQ.ID NO.) 9
(a) sequence signature:
* length: 1320 base pairs
* type: nucleic acid
* chain: two strands
* topological framework: linearity
(b) molecule type: DNA
(c) suppose: not
(d) antisense: not
(e) initial source: Thermoanaerobacterium sachcharolyticum B6A.
1?atgaataaat?attttgagaa?cgtatctaaa?ataaaatatg?aaggaccaaa?atcaaataat
61?ccttattcct?ttaaatttta?caatccagag?gaagtaatcg?atggcaagac?gatggaggag
121?catctccgct?tttctatagc?ttattggcac?acttttactg?ctgatggaac?agatcaattt
181?ggcaaggcta?ctatgcaaag?accatggaac?cactacacag?atcctatgga?tatagcgaaa
241?gcaagggtag?aagcagcatt?tgagtttttt?gataagataa?atgcaccttt?cttctgcttc
301?catgataggg?atattgcccc?tgaaggagat?actcttagag?agacaaacaa?aaacttagat
361?acaatagttg?ctatgataaa?ggattactta?aagaccagca?agacaaaagt?tttgtttggt
421?accgcaaatc?ttttctccaa?tccgagattt?gtacatggtg?catcaacatc?ctgcaatgct
481?gacgtttttg?catattctgc?agcgcaagtc?aaaaaagccc?ttgagattac?taaggagctt
541?ggcgcggaaa?actacacatt?ttggggtgga?agagaagggt?acgagacgct?tctcaataca
601?gatatggagt?tagagcttga?taactttgca?agatttttgc?acatggctgt?tgactatgca
661?aaggaaatcg?gctttgaagg?tcagttcttg?attgagccga?agccaaagga?gcctacaaaa
721?catcaatacg?actttgacgt?ggcaaatgta?ttggcattct?tgagaaaata?cgaccttgac
781?aaatatttca?aagtaaatat?cgaagcaaac?catgcgacat?tggcattcca?cgacttccaa
841?catgagctAa?gatacgccag?aataaacggt?gtattaggat?caattgacgc?aaatgaaggc
901?gacatgcttt?tgggatggga?tacggaccag?ttccctacag?atatacgcat?gacaacgctt
961?gctatgtatg?aagtcataaa?gatgggtgga?tttgacaaag?gtggccttaa?ctttgatgca
1021?aaagtaagac?gtgcttcatt?tgagccagaa?gatcttttct?taggtcacat?agcaggaatg
1081?gatgcttttg?caaaaggctt?taaagttgct?tacaagcttg?tgaaagatgg?cgtatttgac
1141?aagttcatcg?aagaaagata?cgcaagctac?aaagaaggca?ttggcgctga?tattgtaagc
1201?ggtaaagctg?acttcaagag?ccttgaaaag?tatgcattag?agcacagcca?gattgtaaac
1261?aaatcaggca?gacaagagct?attagaatca?atcctaaatc?agtatttgtt?tgcagaataa
Sequence (SEQ.ID NO.) 10
(a) sequence signature:
* length: 440 amino-acid residues
* type: polypeptide
* chain: strand
* topological framework: linearity
(b) molecule type: Protein
(c) suppose: not
(d) antisense: not
(e) initial source: Thermoanaerobacterium sachcharolyticum B6A.
MNKYFENVSKIKYEGPKSNNPYSFKFYNPEEVIDGKTMEEHLRFSIAYWHTFTADGTDQF
GKATMQRPWNHYTDPMDIAKARVEAAFEFFDKINAPFFCFHDRDIAPEGDTLRETNKNLD
TIVAMIKDYLKTSKTKVLFGTANLFSNPRFVHGASTSCNADVFAYSAAQVKKALEITKEL
GAENYTFWGGREGYETLLNTDMELELDNFARFLHMAVDYAKEIGFEGQFLIEPKPKEPTK
HQYDFDVANVLAFLRKYDLDKYFKVNIEANHATLAFHDFQHELRYARINGVLGSIDANEG
DMLLGWDTDQFPTDIRMTTLAMYEVIKMGGFDKGGLNFDAKVRRASFEPEDLFLGHIAGM
DAFAKGFKVAYKLVKDGVFDKFIEERYASYKEGIGADIVSGKADFKSLEKYALEHSQIVN
KSGRQELLESILNQYLFAE*
Claims (16)
1. a seminal fluid fructose is measured novel method, it is characterized in that: this method has used a kind of energy efficient catalytic fructose to be converted into the high reactivity glucose isomerase of glucose.
2. claim 1 a described measuring method, its feature also is: use chelex 100 resins or its analogue to remove glucose isomerase enzyme reaction interfering substance in the seminal fluid.
3. isolated DNA molecule is characterized in that: it is the nucleotide sequence of coding claim 1 a described high reactivity glucose isomerase.
4. claim 3 a described dna molecular, it is characterized in that: described nucleotide sequence has the nucleotide sequence of sequence table SEQ .IDNO.3 or the mutant form of described nucleotide sequence (having 〉=75% homology), and described sudden change comprises: disappearance, nonsense, insertion, missense.
5. claim 4 a described dna molecular, it is characterized in that: the polypeptide of the aminoacid sequence among the described nucleotide sequence coded sequence table SEQ .IDNO.4 or the modified forms of described polypeptide (having 〉=90% homology), on this modified forms function quite or relevant with the high reactivity glucose isomerase.
6. claim 3 a described dna molecular, its feature also is: described nucleotide sequence has the nucleotide sequence of sequence table SEQ .IDNO.5 or the mutant form of described nucleotide sequence (having 〉=75% homology), and described sudden change comprises: disappearance, nonsense, insertion, missense.
7. claim 6 a described dna molecular, it is characterized in that: the polypeptide of the aminoacid sequence among the described nucleotide sequence coded sequence table SEQ .IDNO.6 or the modified forms of described polypeptide (having 〉=90% homology), on this modified forms function quite or relevant with the high reactivity glucose isomerase.
8. claim 3 a described dna molecular, its feature also is: described nucleotide sequence has the nucleotide sequence of sequence table SEQ .IDNO.7 or the mutant form of described nucleotide sequence (having 〉=75% homology), and described sudden change comprises: disappearance, nonsense, insertion, missense.
9. claim 8 a described dna molecular, it is characterized in that: the polypeptide of the aminoacid sequence among the described nucleotide sequence coded sequence table SEQ .IDNO.8 or the modified forms of described polypeptide (having 〉=90% homology), on this modified forms function quite or relevant with the high reactivity glucose isomerase.
10. claim 3 a described dna molecular, its feature also is: described nucleotide sequence has the nucleotide sequence of sequence table SEQ .ID NO.9 or the mutant form of described nucleotide sequence (having 〉=75% homology), and described sudden change comprises: disappearance, nonsense, insertion, missense.
11. claim 10 a described dna molecular, it is characterized in that: the polypeptide of the aminoacid sequence among the described nucleotide sequence coded sequence table SEQ .ID NO.10 or the modified forms of described polypeptide (having 〉=90% homology), on this modified forms function quite or relevant with the high reactivity glucose isomerase.
12. as claim 1 a described high reactivity glucose isomerase is the enzyme of partial purification or complete purifying.
13. as claim 1 a described high reactivity glucose isomerase is liquid phase enzyme or solid enzyme.
14. as claim 1 a described high reactivity glucose isomerase can be to be present in intestinal bacteria, yeast or other protokaryon or the eukaryotic cells with the solid phase cells form.
15. claim 1 a described seminal fluid fructose measuring method can be used for the male sterility diagnosis.
16. claim 1 a described seminal fluid fructose measuring method also can be used on the fructose content of measuring other organism seminal fluid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410037442 CN1693476A (en) | 2004-05-08 | 2004-05-08 | New determination method of semen fructose and glucose isomerase mutant used for said method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410037442 CN1693476A (en) | 2004-05-08 | 2004-05-08 | New determination method of semen fructose and glucose isomerase mutant used for said method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1693476A true CN1693476A (en) | 2005-11-09 |
Family
ID=35352603
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410037442 Withdrawn CN1693476A (en) | 2004-05-08 | 2004-05-08 | New determination method of semen fructose and glucose isomerase mutant used for said method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1693476A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1956083A1 (en) * | 2005-11-18 | 2008-08-13 | Bioright Worldwide Company Limited | Glucose isomerase mutants, the use thereof and the dnas encoding the same |
| CN102012374A (en) * | 2010-09-29 | 2011-04-13 | 南京欣迪生物药业工程有限责任公司 | Kit for detecting concentration of seminal plasma fructose and detection method |
| CN116121217A (en) * | 2023-02-24 | 2023-05-16 | 山东大学 | Glucose oxidase mutant with improved xylose oxidizing ability and application thereof |
-
2004
- 2004-05-08 CN CN 200410037442 patent/CN1693476A/en not_active Withdrawn
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1956083A1 (en) * | 2005-11-18 | 2008-08-13 | Bioright Worldwide Company Limited | Glucose isomerase mutants, the use thereof and the dnas encoding the same |
| EP1956083A4 (en) * | 2005-11-18 | 2009-02-25 | Geneharbor Hong Kong Technolog | Glucose isomerase mutants, the use thereof and the dnas encoding the same |
| US7704719B2 (en) | 2005-11-18 | 2010-04-27 | Geneharbor (Hk) Technologies Ltd. | Glucose isomerase mutants, DNA thereof and use thereof |
| US7923222B2 (en) | 2005-11-18 | 2011-04-12 | Geneharbor (Hk) Technologies Ltd. | Methods of using isolated glucose isomerase |
| US8067561B2 (en) | 2005-11-18 | 2011-11-29 | Bioright Worldwide Company Limited | Isolated DNA encoding recombinant glucose isomerase |
| CN102012374A (en) * | 2010-09-29 | 2011-04-13 | 南京欣迪生物药业工程有限责任公司 | Kit for detecting concentration of seminal plasma fructose and detection method |
| CN102012374B (en) * | 2010-09-29 | 2012-08-01 | 南京欣迪生物药业工程有限责任公司 | Kit for detecting concentration of seminal plasma fructose and detection method |
| CN116121217A (en) * | 2023-02-24 | 2023-05-16 | 山东大学 | Glucose oxidase mutant with improved xylose oxidizing ability and application thereof |
| CN116121217B (en) * | 2023-02-24 | 2023-09-08 | 山东大学 | Glucose oxidase mutant with improved xylose oxidizing ability and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1054639C (en) | DNA fragment encoding polypeptide having nitrile hydratase activity, transformant containing gene and process for production amides using transformant | |
| CN1288242C (en) | Glucose dehydrogenase | |
| CN1039616A (en) | Pichia pastoris alcohol oxidase ii regulatory region | |
| CN1170041A (en) | Novel nitrile hydratase | |
| CN1283780C (en) | Method for constructing genetic engineering fungus of monascus with no citrinin | |
| CN1641019A (en) | Cephalosporin C acylases | |
| CN1693473A (en) | Method of prepairing peltoglucose syrup and high temperature resistant glucose isomerase mutant | |
| CN1306034C (en) | Glucose dehydrogenase | |
| CN1788087A (en) | Alcohol dehydrogenase gene of acetic acid bacterium | |
| CN1202244C (en) | Novel protein having aspartase activity and gene DNA coding for the same | |
| CN1350592A (en) | Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms | |
| CN1243831C (en) | Novel fructosyl amino acid oxidase | |
| CN1228447C (en) | Recombinant expression vector expressing human pancreatic tissue kallikrein gene and prepn of human pancreatic tissue kallikrein | |
| CN1693476A (en) | New determination method of semen fructose and glucose isomerase mutant used for said method | |
| CN1958796A (en) | Nucleotide sequence protein gene of coded natrium hydrogen pump, and application | |
| CN1884508A (en) | Mutant xylose isomerase and gene thereof | |
| CN1743454A (en) | Glucose isomerase mutant and its use | |
| CN1772903A (en) | New-type froctosan saccharase gene and its use | |
| CN1671839A (en) | Glucose dehydrogenase | |
| CN1829798A (en) | Protease, DNA coding for the protease and process for producing the protease | |
| CN100343388C (en) | Thermostable ribonuclease H | |
| CN1257269C (en) | Method for producing 7-amino cephalosporanic acid and its specific recombinase | |
| CN1515680A (en) | Application of ion channel inhibitor for curing arhythmia | |
| CN1807639A (en) | L-lactate dehydrogenase gene and its coded amino acid sequence and the primer designed in preparation process | |
| CN1301266C (en) | High molecular wheat glutelin subunit, genes encoding same and use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20060428 Address after: The British Virgin Islands of Tortola Applicant after: Bairui Global Co., Ltd. Address before: Box 16, building 204, Guanyin District, Beijing, Daxing District 2-502 Applicant before: Zhang Jun |
|
| C04 | Withdrawal of patent application after publication (patent law 2001) | ||
| WW01 | Invention patent application withdrawn after publication |